Severe mental illness linked to higher death rate after heart attack hillingdontimes.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hillingdontimes.co.uk Daily Mail and Mail on Sunday newspapers.
| UPDATED: 15:11, Thu, Feb 25, 2021
Link copied Sign up for FREE now and never miss the top politics stories again
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.
The French President claimed the AstraZeneca jab was quasi-ineffective in January, not long before the EU s drugs regulator approved the use of the vaccine for all adults. The comment concerned other EU leaders who have since reportedly challenged the French President.
Here s what has to happen before the Johnson & Johnson vaccine will be available
From CNN s Jacqueline Howard and Jen Christensen
This file photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States, on December 2, 2020. Johnson & Johnson via AP
Johnson & Johnson says that it has four million doses of its Covid-19 vaccine ready to ship immediately once it receives emergency use authorization, which could happen this week.
In an analysis just released, the US Food and Drug Administration said the company s single-dose vaccine has met the requirements for emergency use authorization.
However, despite the excitement and anticipation, there are still several steps Johnson & Johnson has to go through before the vaccine will be available.
UK data: COVID-19 vaccines sharply cut hospitalizations
By Staff | Feb 23, 2021
Britain s Prime Minister Boris Johnson with quality control technician Kerri Symington, visits the French biotechnology laboratory Valneva in Livingston, Scotland, Thursday Jan. 28, 2021, where they will be producing a COVID-19 vaccine on a large scale, during a visit to Scotland. (Wattie Cheung/Pool via AP)
LONDON (AP) Two U.K. studies released Monday showed that COVID-19 vaccination programs are contributing to a sharp drop in hospitalizations, boosting hopes that the shots will work as well in the real world as they have in carefully controlled studies.
Preliminary results from a study in Scotland found that the Pfizer-BioNTech vaccine reduced hospital admissions by up to 85% four weeks after the first dose, while the Oxford-AstraZeneca shot cut admissions by up to 94%. In England, preliminary data from a study of health care workers showed that the Pfizer vaccine reduced the risk of catching COV